Cost-effectiveness analysis of rituximab with methotrexate,...

  • Main
  • 2020 / 01
  • Cost-effectiveness analysis of rituximab with methotrexate,...

Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma

Beca, Jaclyn M., Raza, Kaiwan, Mow, Elena, Keech, James, Kouroukis, C. Tom
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1711902
Date:
January, 2020
File:
PDF, 1.70 MB
english, 2020
Conversion to is in progress
Conversion to is failed